1Untergasser A,Zedler U,Langenkamp A,et al.Dendritic cells take upviral antigens but do not support the early steps of hepatitis B virus in-fection. Hepatology . 2006
2Xu DZ,Zhao K,Guo LM,et al.A randomized controlled phaseⅡb trial of antigen-antibody immunogenic complex therapeutic vaccine in chronic hepatitis B patients. PLoS One . 2008
3Mahato,R. I.,Cheng,K.,Guntaka,R. V.Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA. Exp. Opin. Drug Del . 2005
4van der Molen RG, Sprengers D, Binda RS, et al. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology, 2004, 40(3 ) : 738-746.
5Tavakoli S, Mederacke I, Herzog-Hauf S, et al. Peripheral blood dendritic cells are phenotypieally and functionally intact in chronic hepatitis B virus(HBV) infection. Clin Exp Immunol, 2008, 151 (1) : 61-70.
6Kaumu S, Ito S, Ishikawa T, et al. Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma and hepatitis B and C virus infection. J Gastroenterol Hepatol, 2000, 15(4) : 4431-4436.
7Maki G. Ex vivo purging of stem cell autografts using cytotoxic cells. J Hematother Stem Cell Res, 2001, 10(4) : 545-549.
8Shi M, Fu J, Shi F, et al. Viral suppression correlates with dendritic cell restoration in chronic hepatitis B patients with autologous cytokine-induced killer cell transfusion. Liver Int, 2008, 29 (3) : 466-474.
9Akbar SM, Kajino K, Tanimoto K, et al, Placebo-controlled trials of vaccination with hepatitis B virus surface antigen in hepatitis B virus transgenic mice. J Hepatol, 1997, 26(1) : 131-137.
10Schimdt-wolf IG, Leftrova P, Mehta BA, et al. Phenotypic characterization and identification of effector cell recognition of cytokine-induced killer cells. Exp Hematol, 1993, 21 ( 13 ) : 1673- 1679.
2Yan YX,Gao YQ,Sun X,et al.Prevalence of hepatitis C virus and hepatitis B virus infections in HIV-positive Chinese patients[J]. Epidemiol Infect,2011,139(3) :354-360.
3Roussos A,Koilakou S,Kalafatas I,et al.Lamivudine treatment for acute severe hepatitis B: report of a case and review of the literature [ J ] .Acta Gastroenterol Belg, 2008,71 ( 1 ) : 30-32.
4Shin SR,Koh KC,Gwak GY,et al.A low viral load predicts a higher initial virologic response to adefovir in patients with Lamivudine- resisitant chronic hepatitis B [J].Gut Liver,2010, 4(4) :530-536.
5Chen CY,Ni YH,Chen HL,et al.Lamivudine treatment in infantile fulminant hepatitis B [J].Pediatr Int,2010,52 (4): 672-674.
6Shin SR,Koh KC,Gwak GY,et al.A low viral load predicts a higher initial virologic response to adefovir in patients with Lamivudine-resisitant chronic hepatitis B [J].Gut Liver,2010,4 (4) :530-536.
7Keiy Y, Cheng G, Mahato RI.RNAi for treating hepatitis B viral infection [ J ].Pharm Res, 2008,25 ( 1 ) : 72-86.
8Morrissey DV, Lockridge JA, Shaw L, et al.Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs [J]. Nat Biotechnol, 2005,23 (8) : 1002-1007.
